Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | TACR1 | P25103 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | FABP3 | P05413 | 1/20 | 0.31 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29757496 | 1.00 | KDM4E (0.36) | KDM4EALOX5KMT2ANPC1RAB9A | |
| SCHEMBL2369745 | 0.80 | ALOX5 (0.47) | KDM4EALOX5KMT2ANPC1RAB9A | |
| SCHEMBL8845375 | 0.76 | KDM4E (0.38) | KDM4EKMT2ANPC1RAB9ALMNA | |
| SCHEMBL30513692 | 0.74 | HPGD (0.43) | KDM4EKMT2ANPC1RAB9ATACR1 | |
| SCHEMBL8840533 | 0.71 | KDM4E (0.37) | KDM4EKMT2ALMNASMN1; SMN2 | |
| SCHEMBL16961382 | 0.71 | HTT (0.46) | KDM4ENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL101014 | 0.70 | KDM4E (0.41) | KDM4EFABP3FABP4LMNA | |
| SCHEMBL3366219 | 0.69 | KDM4E (0.33) | KDM4EFABP3FABP4 | |
| SCHEMBL15787178 | 0.68 | MAOA (0.38) | KDM4E | |
| SCHEMBL922024 | 0.68 | KDM4E (0.35) | KDM4EKMT2AMEN1FABP3FABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 702 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616081-B2 | High precision greenhouse seed and seedling treatment | SYNGENTA CROP PROTECTION AG (CH) | 2026-05-05 | — | — | US | disclosed |
| EP-4723893-A2 | COMPOSITIONS AND METHODS TO MITIGATE PHYTOTOXIC EFFECTS OF AGRICHEMICALS | Ascribe Bioscience Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4717089-A2 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | Syngenta Crop Protection AG (CH) | 2026-04-01 | — | — | EP | disclosed |
| EP-4380933-B1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2026-02-18 | — | — | EP | disclosed |
| US-20260020567-A1 | CRYSTALLINE FORMS OF 1,2,4-OXADIAZOLE FUNGICIDES | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-22 | — | — | US | disclosed |
| US-12528778-B2 | Microbiocidal derivatives | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-20 | — | — | US | disclosed |
| US-12497406-B2 | Microbiocidal derivatives | SYNGENTA CROP PROTECTION AG (CH) | 2025-12-16 | — | — | US | disclosed |
| US-20250368652-A1 | MICROBIOCIDAL BICYCLIC HETEROCYCLIC CARBOXAMIDE DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2025-12-04 | — | — | US | disclosed |
| EP-4655284-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | Syngenta Crop Protection AG (CH) | 2025-12-03 | — | — | EP | disclosed |
| US-12464971-B2 | Sowing device and method for treating seeds during planting | SYNGENTA CROP PROTECTION AG (CH) | 2025-11-11 | — | — | US | disclosed |
| EP-0519211-A1 | Substituted 4-aminopyrimidine, process for their preparation and their use as parasiticide | Hoechst Schering AgrEvo GmbH (DE) | 1992-12-23 | — | — | EP | disclosed |
| US-5116826-A | SILAZANEOPHYL SULFIDES, AND THEIR USE AS PESTICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-05-26 | — | — | US | disclosed |
| US-5002957-A | Insecticides, acaricides, nematocides | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-03-26 | — | — | US | disclosed |
| EP-0386715-A2 | Heteroaryl-aryl-butene and such butane derivatives, process for their preparation, compositions containing them and their use as biocides | Hoechst Schering AgrEvo GmbH (DE) | 1990-09-12 | — | — | EP | disclosed |
| EP-0336199-A1 | Azaneophyl and silazaneophyl sulfides, process for their preparation, agents containing them, and their use as pesticides | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-10-11 | — | — | EP | disclosed |
| US-4855309-A | Pyridine derivatives, agents containing same, and the use thereof as pesticides | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-08-08 | — | — | US | disclosed |
| EP-0318882-A2 | (Thio)benzoyl ureas, functional derivatives, process for their preparation, compositions and pesticidal use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-06-07 | — | — | EP | disclosed |
| EP-0243790-A1 | N-phenyl(thio)ureas and their functional derivatives, processes for their production and their use as pesticides | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-11-04 | — | — | EP | disclosed |
| EP-0227046-A2 | Pyridine derivatives, process for their preparation, agents containing them and their use as pesticides | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-07-01 | — | — | EP | disclosed |
| EP-0199945-A2 | Carbamoylarylcarboximide-acid esters, process for their preparation, compositions containing them and their use as pesticides | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-11-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368652-A1 | MICROBIOCIDAL BICYCLIC HETEROCYCLIC CARBOXAMIDE DERIVATIVES | CASP1, ARG2, MPO | KDM4E 1491/4885ALOX5 925/4885KMT2A 2541/4885 |
| US-12616081-B2 | High precision greenhouse seed and seedling treatment | DCX, MYB, CROCC | KDM4E 4269/4885ALOX5 4030/4885KMT2A 4512/4885 |
| US-12528778-B2 | Microbiocidal derivatives | CCR1, CCR6, CCRL2 | KDM4E 2248/4885ALOX5 1249/4885KMT2A 3429/4885 |
| US-20260020567-A1 | CRYSTALLINE FORMS OF 1,2,4-OXADIAZOLE FUNGICIDES | CYP51A1, CYP4B1, CYP8B1 | KDM4E 4144/4885ALOX5 2562/4885KMT2A 4576/4885 |
| US-12497406-B2 | Microbiocidal derivatives | MPO, PRF1, MSR1 | KDM4E 2058/4885ALOX5 808/4885KMT2A 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.